The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II
Open accessAbstract
Despite the benefits of currently available preventative and therapeutic interventions, atherosclerotic vascular disease continues to be a major cause of morbidity and mortality in much of the Western World. This emphasize,,, the need for additional preventive and therapeutic interventions exploiting new targets to compliment and augment the results of LDL lowering and other current strategies. One such potential target is HDL and its apolipoproteins, A large body of experimental evidence suggests that augmenting the levels and/or function of HDL and its apolipoproteins can have major vascular protective effects ranging from prevention to stabilization and regression, independent of total or non-HDL cholesterol levels. Therefore, we think that the time is ripe for the development and clinical testing of this new frontier in antiatherogenic strategy. In the present article, We will review the structure/function of HDL and explore means of enhancing the levels and/or function of HDL and its apolipoproteins for vascular protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,648
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,611
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Atherosclerosis is an inflammatory disease
Ross, R. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70266-8 · Cited by 1,451
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics · doi:10.1038/11921 · Cited by 1,433
The role of oxidized lipoproteins in atherogenesis
Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,366
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J.-M. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,301
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,204
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005
Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231404 · Cited by 1,001
Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X Receptor
Costet, P., Luo, Y., Wang, N., & Tall, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003337200 · Cited by 979
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 861
MACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
Cockerill, G. W., Rye, K.-A., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 783
Badimon, J. J., Badimon, L., & Fuster, V (1990) · Journal of Clinical Investigation · doi:10.1172/jci114558 · Cited by 764
Lawn, R. M., Wade, D. P., Garvin, M. R., Wang, X., Schwartz, K., Porter, J. G., Seilhamer, J. J., Vaughan, A. M., & Oram, J. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8119 · Cited by 724
Navab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 692
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
Libby, P., & Hansson, G. K. (1991) · PubMed · Cited by 663
Zhong, S., Sharp, D. S., Grove, J. S., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 583
Plump, A. S., Scott, C. J., & Breslow, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9607 · Cited by 568
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., & Shinkai, H. (2000) · Nature · doi:10.1038/35018119 · Cited by 531
Lipoproteins, Cardiovascular Disease, and Death: The Framingham Study
Gordon, T. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090024008 · Cited by 526
Cell cholesterol efflux: integration of old and new observations provides new insights
Rothblat, G. H., de la Llera-Moya, M., Atger, V., Kellner-Weibel, G., Williams, D. L., & Phillips, M. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32113-1 · Cited by 503
Kannel, W. B., Neaton, J. D., Wentworth, D., Thomas, H. E., Stamler, J., Hulley, S. B., & Kjelsberg, M. O. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90481-3 · Cited by 501
Langmann, T., Klucken, J., Reil, M., Liebisch, G., Luciani, M.-F., Chimini, G., Kaminski, W. E., & Schmitz, G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0406 · Cited by 492
Franceschini, G., Sirtori, C. R., Capurso, A., Weisgraber, K. H., & Mahley, R. W. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109956 · Cited by 472
Miller, N. E. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90638-7 · Cited by 468
Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins
Mackness, M. I., Mackness, B., Durrington, P. N., Connelly, P. W., & Hegele, R. A. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199604000-00004 · Cited by 447
Abbott, R. D., Wilson, P. W., Kannel, W. B., & Castelli, W. P. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.3.207 · Cited by 436
Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
Martin, G., Duez, H., Blanquart, C., Berezowski, V., Poulain, P., Fruchart, J.-C., Najib-Fruchart, J., Glineur, C., & Staels, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10852 · Cited by 417
ABC1 Gene Expression and ApoA-I-Mediated Cholesterol Efflux Are Regulated by LXR
Schwartz, K., Lawn, R. M., & Wade, D. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3243 · Cited by 410
Watson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., McIntyre, T. M., Du, B. N., Fogelman, A. M., & Berliner, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117726 · Cited by 403
The response‐to‐retention hypothesis of atherogenesis reinforced
Williams, K. J., & Tabas, I. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00012 · Cited by 395
Frick, M. H., Syvänne, M., Nieminen, M. S., Kauma, H., Majahalme, S., Virtanen, V., Kesäniemi, Y. A., Pasternack, A., & Taskinen, M.-R. (1997) · Circulation · doi:10.1161/01.cir.96.7.2137 · Cited by 388
Abbott, C. A., Mackness, M. I., Kumar, S., Boulton, A. J., & Durrington, P. N. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1812 · Cited by 387
Shah, P. K., Yano, J., Reyes, O., Chyu, K.-Y., Kaul, S., Bisgaier, C. L., Drake, S., & Cercek, B. (2001) · Circulation · doi:10.1161/hc2501.092494 · Cited by 381
Self-citationMackness, B., Mackness, M. I., Arrol, S., Turkie, W., & Durrington, P. N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00064-7 · Cited by 377
Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
Pászty, C., Maeda, N., Verstuyft, J., & Rubin, E. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117412 · Cited by 374
Atherosclerosis in Transgenic Mice Overexpressing Apolipoprotein A-II
Warden, C. H., Hedrick, C. C., Qiao, J.-H., Castellani, L. W., & Lusis, A. J. (1993) · Science · doi:10.1126/science.8332912 · Cited by 360
Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice
Tangirala, R. K., Tsukamoto, K., Chun, S. H., Usher, D., Puré, E., & Rader, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.17.1816 · Cited by 358
Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux
Marcil, M., Brooks-Wilson, A., Clee, S. M., Roomp, K., Zhang, L.-H., Yu, L., Collins, J. A., van Dam, M., Molhuizen, H. O., Loubster, O., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)07026-9 · Cited by 352
Mackness, B., Durrington, P. N., & Mackness, M. I. (1998) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(98)00028-7 · Cited by 350
Kozarsky, K. F., Donahee, M. H., Glick, J. M., Krieger, M., & Rader, D. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.721 · Cited by 337
Apolipoprotein A-I containing lipoproteins in coronary artery disease
Puchois, P., Kandoussi, A., Fievet, P., Fourrier, J. L., Bertrand, M., Koren, E., & Fruchart, J. C. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90091-8 · Cited by 326
High Density Lipoproteins and Atherosclerosis
Miller, G. J. (1980) · Annual Review of Medicine · doi:10.1146/annurev.me.31.020180.000525 · Cited by 324
Atheroprotective mechanisms of HDL
Stein, O., & Stein, Y. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00065-9 · Cited by 316
Rittershaus, C. W., Miller, D. P., Thomas, L. J., Picard, M. D., Honan, C. M., Emmett, C. D., Pettey, C. L., Adari, H., Hammond, R. A., Beattie, D. T., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2106 · Cited by 312
Claudel, T., Leibowitz, M. D., Fiévet, C., Tailleux, A., Wagner, B., Repa, J. J., Torpier, G., Lobaccaro, J.-M., Paterniti, J. R., Mangelsdorf, D. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041609298 · Cited by 292
Hirano, K.-I., Yamashita, S., Nakajima, N., Arai, T., Maruyama, T., Yoshida, Y., Ishigami, M., Sakai, N., Kameda-Takemura, K., & Matsuzawa, Y. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1053 · Cited by 275
Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
Schultz, J. R., Verstuyft, J. G., Gong, E. L., Nichols, A. V., & Rubin, E. M. (1993) · Nature · doi:10.1038/365762a0 · Cited by 275
Kozyraki, R., Fyfe, J., Kristiansen, M., Gerdes, C., Jacobsen, C., Cui, S., Christensen, E. I., Aminoff, M., de la Chapelle, A., Krahe, R., et al. (1999) · Nature Medicine · doi:10.1038/9504 · Cited by 273
Remaley, A. T., Rust, S., Rosier, M., Knapper, C., Naudin, L., Broccardo, C., Peterson, K. M., Koch, C., Arnould, I., Prades, C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12685 · Cited by 269
ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins
Oram, J. F., & Vaughan, A. M. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00005 · Cited by 264
Zeiher, A. M., Schächlinger, V, Hohnloser, S. H., Saurbier, B., & Just, H. (1994) · Circulation · doi:10.1161/01.cir.89.6.2525 · Cited by 259
PLASMA LIPID TRANSFER PROTEINS, HIGH-DENSITY LIPOPROTEINS, AND REVERSE CHOLESTEROL TRANSPORT
Bruce, C., Chouinard, R. A., & Tall, A. R. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.297 · Cited by 258
Coronary risk factors, endothelial function, and atherosclerosis: A review
Vogel, R. A. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200505 · Cited by 256
Shih, D. M., Gu, L., Hama, S., Xia, Y. R., Navab, M., Fogelman, A. M., & Lusis, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118589 · Cited by 247
Shah, P. K., Nilsson, J., Kaul, S., Fishbein, M. C., Ageland, H., Hamsten, A., Johansson, J., Karpe, F., & Cercek, B. (1998) · Circulation · doi:10.1161/01.cir.97.8.780 · Cited by 239
Self-citationde la Llera-Moya, M., Rothblat, G. H., Connelly, M. A., Kellner-Weibel, G., Sakr, S. W., Phillips, M. C., & Williams, D. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32462-7 · Cited by 234
High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway
Xia, P., Vadas, M. A., Rye, K.-A., Barter, P. J., & Gamble, J. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33143 · Cited by 233
Griffin, J. H., Kojima, K., Banka, C. L., Curtiss, L. K., & Fernández, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5006 · Cited by 232
Eriksson, M., Carlson, L. A., Miettinen, T. A., & Angelin, B. (1999) · Circulation · doi:10.1161/01.cir.100.6.594 · Cited by 228
Simon, D. I., Chen, Z., Seifert, P., Edelman, E. R., Ballantyne, C. M., & Rogers, C. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7811 · Cited by 228
Duverger, N., Kruth, H., Emmanuel, F., Caillaud, J.-M., Viglietta, C., Castro, G., Tailleux, A., Fievet, C., Fruchart, J. C., Houdebine, L. M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.4.713 · Cited by 225
Weisgraber, K. H., Bersot, T. P., Mahley, R. W., Franceschini, G., & Sirtori, C. R. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109957 · Cited by 216
Sharrett, A. R., Patsch, W., Sorlie, P. D., Heiss, G., Bond, M. G., & Davis, C. E. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1098 · Cited by 214
High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits.
Jj, B., Badimón, L., Galvez, A., Dische, R., & Fuster, V. (1989) · PubMed · Cited by 214
Connelly, M. A., Klein, S. M., Azhar, S., Abumrad, N. A., & Williams, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.41 · Cited by 213
Mackness, B., Hunt, R., Durrington, P. N., & Mackness, M. I. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.7.1233 · Cited by 210
Bérard, A. M., Föger, B., Remaley, A., Shamburek, R., Vaisman, B. L., Talley, G., Paigen, B., Hoyt, R. F., Marcovina, S., Brewer, H. B., et al. (1997) · Nature Medicine · doi:10.1038/nm0797-744 · Cited by 209
Paraoxonase and coronary heart disease
Mackness, M. I., Mackness, B., Durrington, P. N., Fogelman, A. M., Berliner, J., Lusis, A. J., Navab, M., Shih, D., & Fonarow, G. C. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199808000-00006 · Cited by 204
Fielding, C. J., & Fielding, P. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3911 · Cited by 196
Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., Sakai, M., Hakamata, H., Sakamoto, Y.-I., Naito, M., et al. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1882 · Cited by 191
Mendez, A. J., Anantharamaiah, G. M., Segrest, J. P., & Oram, J. F. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117515 · Cited by 189
Castellani, L. W., Navab, M., Van Lenten, B. J., Hedrick, C. C., Hama, S. Y., Goto, A. M., Fogelman, A. M., & Lusis, A. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119554 · Cited by 184
Ameli, S., Hultgardh-Nilsson, A., Cercek, B., Shah, P. K., Forrester, J. S., Ageland, H., & Nilsson, J. (1994) · Circulation · doi:10.1161/01.cir.90.4.1935 · Cited by 184
Self-citationMolecular mechanisms of reverse cholesterol transport
Barter, P. J., & Rye, K.-A. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199604000-00006 · Cited by 181
Cohen, R. D., Castellani, L. W., Qiao, J. H., Van Lenten, B. J., Lusis, A. J., & Reue, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119358 · Cited by 165
Heart Attacks: Gone with the Century?
Brown, M. S., & Goldstein, J. L. (1996) · Science · doi:10.1126/science.272.5262.629 · Cited by 163
Pathogenesis of atherosclerosis
Navab, M., Fogelman, A. M., Berliner, J. A., Territo, M. C., Demer, L. L., Frank, J. S., Watson, A. D., Edwards, P. A., & Lusis, A. J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80466-4 · Cited by 162
1999 George Lyman Duff Memorial Lecture: Lipid Transfer Proteins, HDL Metabolism, and Atherogenesis
Tall, A. R., Jiang, X., Luo, Y., & Silver, D. L. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1185 · Cited by 162
Matsuda, Y., Hirata, K., Inoue, N., Suematsu, M., Kawashima, S., Akita, H., & Yokoyama, M. (1993) · Circulation Research · doi:10.1161/01.res.72.5.1103 · Cited by 160
The antiatherogenic role of high-density lipoprotein cholesterol
Kwiterovich, P. O. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00808-x · Cited by 160
Nanjee, M. N., Doran, J. E., Lerch, P. G., & Miller, N. E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.979 · Cited by 158
Leitinger, N., Watson, A. D., Hama, S. Y., Ivandic, B., Qiao, J.-H., Huber, J., Faull, K. F., Grass, D., Navab, M., Fogelman, A. M., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1291 · Cited by 154
Structure and function of apolipoprotein A-I and high-density lipoprotein
Segrest, J. P., Li, L., Anantharamaiah, G. M., Harvey, S. C., Liadaki, K. N., & Zannis, V. I. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200004000-00002 · Cited by 151
Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models
Benoit, P., Emmanuel, F., Caillaud, J. M., Bassinet, L., Castro, G. R., Gallix, P., Fruchart, J., Branellec, D., Denèfle, P., & Duverger, N. (1999) · Circulation · doi:10.1161/01.cir.99.1.105 · Cited by 147
Toikka, J., Ahotupa, M. O., Viikari, J. S. A., Niinikoski, H., Taskinen, M., Irjala, K., Hartiala, J., & Raitakari, O. T. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00186-0 · Cited by 143
Inhibition of Arterial Thrombus Formation by ApoA1 Milano
Li, D., Weng, S., Yang, B., Zander, D. S., Saldeen, T. G. P., Nichols, W. W., Khan, S. R., & Mehta, J. L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.378 · Cited by 143
Hannuksela, M. L., Liinamaa, J., Kesäniemi, Y. A., & Savolainen, M. J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90065-5 · Cited by 138
Subbanagounder, G., Leitinger, N., Shih, P. T., Faull, K. F., & Berliner, J. A. (1999) · Circulation Research · doi:10.1161/01.res.85.4.311 · Cited by 138
Naqvi, T. Z., Shah, P. K., Ivey, P. A., Molloy, M. D., Thomas, A. M., Panicker, S., Ahmed, A. E. E., Cercek, B., & Kaul, S. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00489-0 · Cited by 134
Self-citationDimayuga, P. C., Zhu, J., Oguchi, S., Chyu, K., Xu, X.-O. H., Yano, J., Shah, P. K., Nilsson, J. Å., & Cercek, B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1278 · Cited by 129
Self-citationCao, H., Girard-Globa, A., Berthézène, F., & Moulin, P. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33348-4 · Cited by 125
Crouse, J. R., Frohlich, J. J., Ose, L., Mercuri, M. F., & Tobert, J. A. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00153-8 · Cited by 124
Liu, A. C., Lawn, R. M., Verstuyft, J. G., & Rubin, E. M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39932-6 · Cited by 117
Increased Cholesterol Efflux Potential of Sera From ApoA-I Milano Carriers and Transgenic Mice
Franceschini, G., Calabresi, L., Chiesa, G., Parolini, C., Sirtori, C. R., Canavesi, M., & Bernini, F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1257 · Cited by 116
Reverse Cholesterol Transport—A Review of the Process and Its Clinical Implications
Hill, S., & McQueen, M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00098-2 · Cited by 115
Reverse cholesterol transport: Physiology and pharmacology
Franceschini, G., MADERNA, P., & Sirtori, C. R. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90073-c · Cited by 115
Voyiaziakis, E., Goldberg, I. J., Plump, A. S., Rubin, E. M., Breslow, J. L., & Huang, L. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33893-1 · Cited by 111
Barter, P. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2029 · Cited by 107
Hamilton, K. K., Zhao, J., & Sims, P. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53740-6 · Cited by 102
Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans
Nanjee, M. N., Crouse, J. R., King, J. M., Hovorka, R., Rees, S. E., Carson, E. R., Morgenthaler, J. ‐., Lerch, P., & Miller, N. E. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1203 · Cited by 100
Soma, M. R., Donetti, E., Parolini, C., Sirtori, C. R., Fumagalli, R., & Franceschini, G. (1995) · Circulation Research · doi:10.1161/01.res.76.3.405 · Cited by 97
Geest, B. D., Zhao, Z., Collen, D., & Holvoet, P. (1997) · Circulation · doi:10.1161/01.cir.96.12.4349 · Cited by 96
Role of high density lipoproteins in the regression of atherosclerosis.
Badimon, J. J., Fuster, V., & Badimón, L. (1992) · PubMed · Cited by 91
Ericsson, C.-G., Nilsson, J. Å., Grip, L., Svane, B., & Hamsten, A. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00626-7 · Cited by 91
Self-citationSaxena, U., Ferguson, E., & Bisgaier, C. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82406-1 · Cited by 89
Graham, A., Hassall, D. G., Rafique, S., & Owen, J. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00162-7 · Cited by 88
The Helsinki Heart Study: Central Findings and Clinical Implications
Huttunen, J. K., Manninen, V., Mänttäri, M., Koskinen, P., Romo, M., Tenkanen, L., Heinonen, O. P., & Frick, M. H. (1991) · Annals of Medicine · doi:10.3109/07853899109148041 · Cited by 85
Heinecke, J. W., & Lusis, A. J. (1998) · The American Journal of Human Genetics · doi:10.1086/301691 · Cited by 84
PLAQUE DISRUPTION AND THROMBOSIS
Shah, P. K. (1999) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70074-6 · Cited by 82
Self-citationCholesterol, cholesterol lowering, and endothelial function
VOGEL, R., Corretti, M. C., & Gellman, J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80008-x · Cited by 81
High Density Lipoproteins in Health and in Disease
Genest, J. J., Marcil, M., Denis, M., & Yu, L. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700106 · Cited by 80
New Perspectives on the Management of Low Levels of High-Density Lipoprotein Cholesterol
Harper, C. R., & Jacobson, T. A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1049 · Cited by 72
Studies of Synthetic Peptides of Human Apolipoprotein A-I Containing Tandem Amphipathic α-Helixes
Mishra, V., Palgunachari, M. N., Datta, G., Phillips, M. C., Lund‐Katz, S., Adeyeye, S. O., Segrest, J. P., & Anantharamaiah, G. M. (1998) · Biochemistry · doi:10.1021/bi980042o · Cited by 71
Reverse Cholesterol Transport and Atherosclerosis Regression
Spady, D. K. (1999) · Circulation · doi:10.1161/01.cir.100.6.576 · Cited by 69
Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors
Fager, G., Wiklund, O., Olofsson, S., Wilhelmsson, C., & Bondjers, G. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90199-9 · Cited by 68
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
Bonnefont‐Rousselot, D., Thérond, P., Beaudeux, J., Peynet, J., Legrand, A., & Delattre, J. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.139 · Cited by 68
Castro, G. R., Nihoul, L. P., Dengremont, C., Geitere, C. D., Delfly, B., Tailleux, A., Fiévet, C., Duverger, N., Denèfle, P., Fruchart, J., et al. (1997) · Biochemistry · doi:10.1021/bi961191e · Cited by 67
James, R. W., Blatter, M.-C., Calabresi, L., Miccoli, R., von Eckardstein, A., Tilly-Kiesi, M., Taskinen, M., Assmann, G., & Franceschini, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00058-6 · Cited by 66
Very low high-density lipoproteins without coronary atherosclerosis
Rader, D. J., Ikewaki, K., Duverger, N., Feuerstein, I. M., Brewer, H. B., & CONNOR, W. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92933-k · Cited by 66
The role of apolipoprotein A-l-containing lipoproteins in atherosclerosis
Forte, T. M., & McCall, M. R. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199410000-00007 · Cited by 66
Is paraoxonase related to atherosclerosis
Mackness, M., Arrol, S., Abbott, C. A., & Durrington, P. N. (1993) · Chemico-Biological Interactions · doi:10.1016/0009-2797(93)90038-z · Cited by 65
Kakko, Tamminen, Päivänsalo, Kauma, Rantala, Lilja, Reunanen, Kesäniemi, & Savolainen (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00595.x · Cited by 65
Rodrigueza, W. V., Williams, K. J., Rothblat, G. H., & Phillips, M. C. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.2.383 · Cited by 63
Monocyte adhesion and transmigration in atherosclerosis
Navab, M., Hama, S. Y., Nguyen, T. B., & Fogelman, A. M. (1994) · Coronary Artery Disease · doi:10.1097/00019501-199403000-00003 · Cited by 60
Mikhailidis, D. P., & Wierzbicki, A. S. (2000) · Current Medical Research and Opinion · doi:10.1185/0300799009117018 · Cited by 60
Leitinger, N., Watson, A. D., Faull, K. F., Fogelman, A. M., & Berliner, J. A. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1810-9_82 · Cited by 59
Cholesteryl Ester Transfer Protein Activity Enhances Plasma Cholesteryl Ester Formation
Oliveira, H. C. F., Ma, L., Milne, R. W., Marcovina, S. M., Inazu, A., Mabuchi, H., & Tall, A. R. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1045 · Cited by 56
Effects of serum lipid levels on restenosis after coronary angioplasty
Reis, G. J., Kuntz, R. E., Silverman, D. I., & Pasternak, R. C. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90275-p · Cited by 54
Rodrigueza, W. V., Mazany, K. D., Essenburg, A. D., Pape, M. E., Rea, T. J., Bisgaier, C. L., & Williams, K. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2132 · Cited by 53
Mechanistic studies of high-density lipoproteins
Kashyap, M. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00813-3 · Cited by 53
Human Apolipoproteins A-I and A-II in Cell Cholesterol Efflux: Studies With Transgenic Mice
Chiesa, G., Parolini, C., Canavesi, M., Colombo, N., Sirtori, C. R., Fumagalli, R., Franceschini, G., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1417 · Cited by 52
HDL Deficiency in Genetically Engineered Mice Requires Elevated LDL to Accelerate Atherogenesis
Hughes, S. D., Verstuyft, J. G., & Rubin, E. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1725 · Cited by 51
Lipoprotein (a) concentrations as risk indicators for atherosclerosis.
Kostner, G. M., Czinner, A., Pfeiffer, K. H., & Bihari-Varga, M. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.9.1054 · Cited by 44
INHIBITION OF ENDOTHELIAL CELL ADHESION MOLECULE EXPRESSION BY HIGH DENSITY LIPOPROTEINS
Barter, P. J. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb01821.x · Cited by 43
Williams, K. J., Scalia, R. G., Mazany, K. D., Rodrigueza, W. V., & Lefer, A. M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.1033 · Cited by 43
Luoma, P. (1997) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1997.tb00032.x · Cited by 42
Fruchart, J., Geteire, C. D., Delfly, B., & Castro, G. R. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)05374-r · Cited by 40
An Absorbing Study of Cholesterol
Allayee, H., Laffitte, B. A., & Lusis, A. J. (2000) · Science · doi:10.1126/science.290.5497.1709 · Cited by 38
Atherosclerosis and lipoprotein metabolism: Role of reverse cholesterol transport
Roheim, P. S. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)91020-9 · Cited by 38
Tsukamoto, K., Hiester, K. G., Smith, P., Usher, D. C., Glick, J. M., & Rader, D. J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37161-3 · Cited by 29
Nilsson, J., Dahlgren, B., Ares, M. P. S., Westman, J., Nilsson, A. H., Cercek, B., & Shah, P. K. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.1.13 · Cited by 26
Self-citationHigh-density lipoprotein cholesterol levels as a marker of reverse cholesterol transport
Gwynne, J. T. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90950-8 · Cited by 25
Calcium antagonists and cardiovascular risk in diabetes
Parving, H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00758-9 · Cited by 21
Gene therapy for atherosclerosis
Rader, D. J. (1997) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02827240 · Cited by 21
Cholesteryl Ester Transfer Protein and Atherogenesis
Tall, A. R., Sharp, D. S., Zhong, S., Hayek, T., Masucci-Magoulas, L., Rubin, E. M., & Breslow, J. L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52000.x · Cited by 16
Physiologic role and clinical significance of reverse cholesterol transport
Bleicher, J. M., & Lacko, A. G. (1992) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1992-920514 · Cited by 9
Report on the Lipid Research Clinic trials
Levy, R. I. (1987) · European Heart Journal · doi:10.1093/eurheartj/8.suppl_e.45 · Cited by 8
Is Cholesteryl Ester Transfer Protein (CETP) Deficiency Atherogenic in Familial Hypercholesterolemia
Saitō, Y. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.495 · Cited by 4
Cited by
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tardif, J.-C., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Ruzyllo, W., Bachinsky, W. B., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 966
Atherothrombosis and High-Risk Plaque
Fuster, V., Moreno, P. R., Fayad, Z. A., Corti, R., & Badimon, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.074 · Cited by 738
Endothelial and Antithrombotic Actions of HDL
Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 655
WALLDIUS, G., & JUNGNER, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01643.x · Cited by 583
Metadata
- Authors
- Shah, P. K., Kaul, S., Nilsson, J., & Cercek, B.
- Venue
- Circulation
- Published
- 2001-11-13
- Volume
- 104
- Issue
- 20
- Pages
- 2498-2502
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2140300598
- Cited by
- 295
- References
- 170
- FWCI
- 16.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.